We have located links that may give you full text access.
Aging and APOE-ε4 are determinative factors of plasma A β 42 levels.
Annals of Clinical and Translational Neurology 2018 October
OBJECTIVE: The aim of this study was to confirm determinative factors for plasma A β and its association with cognitive function.
METHODS: Fasting plasma A β 40 and A β 42 levels were measured by ELISA in 1019 participants in the Iwaki Health Promotion Project. The relationships between plasma A β and health-related items, including physical characteristics, cognitive function tests, blood chemistry, and APOE-ε4 genotype were analyzed.
RESULTS: The plasma levels of A β 40 and A β 42, and A β 40/42 ratio were found to significantly increase with aging. The age-dependent increase in A β 42 level was significantly suppressed by APOE-ε4 . Renal function was an associated factor for the plasma A β 40 level. The plasma A β 42 level and A β 40/42 ratio correlated with cognitive function.
INTERPRETATION: Age and APOE-ε4 are major determinative factors of plasma levels of A β 42 and the A β 40/42 ratio. These factors are critical adjustment factors for the usage of plasma A β as a biomarker of central nervous system amyloidosis.
METHODS: Fasting plasma A β 40 and A β 42 levels were measured by ELISA in 1019 participants in the Iwaki Health Promotion Project. The relationships between plasma A β and health-related items, including physical characteristics, cognitive function tests, blood chemistry, and APOE-ε4 genotype were analyzed.
RESULTS: The plasma levels of A β 40 and A β 42, and A β 40/42 ratio were found to significantly increase with aging. The age-dependent increase in A β 42 level was significantly suppressed by APOE-ε4 . Renal function was an associated factor for the plasma A β 40 level. The plasma A β 42 level and A β 40/42 ratio correlated with cognitive function.
INTERPRETATION: Age and APOE-ε4 are major determinative factors of plasma levels of A β 42 and the A β 40/42 ratio. These factors are critical adjustment factors for the usage of plasma A β as a biomarker of central nervous system amyloidosis.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app